Arsenic Toxicity: Molecular Targets and Therapeutic Agents
- PMID: 32033229
- PMCID: PMC7072575
- DOI: 10.3390/biom10020235
Arsenic Toxicity: Molecular Targets and Therapeutic Agents
Abstract
: High arsenic (As) levels in food and drinking water, or under some occupational conditions, can precipitate chronic toxicity and in some cases cancer. Millions of people are exposed to unacceptable amounts of As through drinking water and food. Highly exposed individuals may develop acute, subacute, or chronic signs of poisoning, characterized by skin lesions, cardiovascular symptoms, and in some cases, multi-organ failure. Inorganic arsenite(III) and organic arsenicals with the general formula R-As2+ are bound tightly to thiol groups, particularly to vicinal dithiols such as dihydrolipoic acid (DHLA), which together with some seleno-enzymes constitute vulnerable targets for the toxic action of As. In addition, R-As2+-compounds have even higher affinity to selenol groups, e.g., in thioredoxin reductase that also possesses a thiol group vicinal to the selenol. Inhibition of this and other ROS scavenging seleno-enzymes explain the oxidative stress associated with arsenic poisoning. The development of chelating agents, such as the dithiols BAL (dimercaptopropanol), DMPS (dimercapto-propanesulfonate) and DMSA (dimercaptosuccinic acid), took advantage of the fact that As had high affinity towards vicinal dithiols. Primary prevention by reducing exposure of the millions of people exposed to unacceptable As levels should be the prioritized strategy. However, in acute and subacute and even some cases with chronic As poisonings chelation treatment with therapeutic dithiols, in particular DMPS appears promising as regards alleviation of symptoms. In acute cases, initial treatment with BAL combined with DMPS should be considered.
Keywords: BAL; DMPS; arsenic; arsenic poisoning; drinking water; lipoic acid.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
DMSA, DMPS, and DMPA--as arsenic antidotes.Fundam Appl Toxicol. 1984 Apr;4(2 Pt 2):S58-70. doi: 10.1016/0272-0590(84)90138-6. Fundam Appl Toxicol. 1984. PMID: 6327446
-
Are we ready to replace dimercaprol (BAL) as an arsenic antidote?Hum Exp Toxicol. 1997 Aug;16(8):460-5. doi: 10.1177/096032719701600807. Hum Exp Toxicol. 1997. PMID: 9292286 Review.
-
Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.Hum Exp Toxicol. 1990 Jul;9(4):215-20. doi: 10.1177/096032719000900403. Hum Exp Toxicol. 1990. PMID: 2167707
-
Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water.J Toxicol Clin Toxicol. 2001;39(7):665-74. doi: 10.1081/clt-100108507. J Toxicol Clin Toxicol. 2001. PMID: 11778664 Clinical Trial.
-
Metal chelators and neurotoxicity: lead, mercury, and arsenic.Arch Toxicol. 2017 Dec;91(12):3787-3797. doi: 10.1007/s00204-017-2100-0. Epub 2017 Oct 24. Arch Toxicol. 2017. PMID: 29063135 Review.
Cited by
-
The role of hypoxia-inducible factor 1 alpha (HIF-1α) modulation in heavy metal toxicity.Arch Toxicol. 2023 May;97(5):1299-1318. doi: 10.1007/s00204-023-03483-7. Epub 2023 Mar 18. Arch Toxicol. 2023. PMID: 36933023 Review.
-
Natural Dietary Compounds in the Treatment of Arsenic Toxicity.Molecules. 2022 Jul 29;27(15):4871. doi: 10.3390/molecules27154871. Molecules. 2022. PMID: 35956821 Free PMC article. Review.
-
Toxic-Metal-Induced Alteration in miRNA Expression Profile as a Proposed Mechanism for Disease Development.Cells. 2020 Apr 7;9(4):901. doi: 10.3390/cells9040901. Cells. 2020. PMID: 32272672 Free PMC article. Review.
-
Removal of Aqueous Antimony and Arsenic by Iron-Loaded Coal Gasification Slag Composite.Toxics. 2024 Jun 19;12(6):440. doi: 10.3390/toxics12060440. Toxics. 2024. PMID: 38922120 Free PMC article.
-
Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity.Heliyon. 2025 Jan 21;11(3):e42113. doi: 10.1016/j.heliyon.2025.e42113. eCollection 2025 Feb 15. Heliyon. 2025. PMID: 39916822 Free PMC article.
References
-
- Sackett P.D. Geological Society of America Special Papers. Volume 520. Geological Society of America; Boulder, CO, USA: 2016. Elemental cycles in the Anthropocene: Mining aboveground; pp. 99–116.
-
- Substance Priority List. ATSDR. [(accessed on 24 September 2019)]; Available online: https://www.atsdr.cdc.gov/SPL/
-
- Smoke T., Smoking I. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 100C. International Agency for Research on Cancer; Lyon, France: 2004.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials